Spelling suggestions: "subject:"kyrosine. 1phosphorylation."" "subject:"kyrosine. dphosphorylation.""
41 |
Estudio de la funcionalidad espermática, interacción de gametos y análisis proteico en espermatozoides Epididimarios y Eyaculados en la especie porcinaAvilés López, Karen Guadalupe 29 September 2011 (has links)
La capacitación es un proceso fisiológico que el espermatozoide debe experimentar para que la fecundación del ovocito tenga lugar. Este proceso se encuentra regulado en el espermatozoide por diferentes vías moleculares, varias de las cuales, a día de hoy, se desconocen o no están totalmente dilucidadas. Estos eventos moleculares que acontecen en el espermatozoide durante el proceso de capacitación están condicionados por distintos factores que rodean su entorno, entre los cuales podemos destacar el ambiente epididimario, el plasma seminal o las secreciones del aparato reproductor femenino como el fluido oviductal.
El objetivo principal de este trabajo fue analizar el comportamiento de espermatozoides epididimarios-EP (en contacto con el fluido epididimario y no con el plasma seminal) y eyaculados-EY (en contacto con el plasma seminal) sometidos a 3 tratamientos diferentes: 1) Espermatozoides no tratados (grupo control-C); 2) Lavados a través de gradientes de Percoll e incubados en medio de capacitación TALP (grupo lavados-L); 3) Espermatozoides lavados e incubados en Fluido Oviductal Porcino (grupo FOP).
|
42 |
Structural And Mechanistic Studies On Receptor Protein Tyrosine Phosphatases From Drosophila MelanogasterMadan, Lalima Lochan 09 1900 (has links) (PDF)
Protein Tyrosine Phosphatases (PTPs) initiate, modulate and terminate key cellular processes by dephosphorylating phosphotyrosine (pY) residues on signaling proteins. The coordinated action of PTPs with their cognate tyrosine kinases is crucial for the maintenance of cellular homeostasis. Five Receptor Tyrosine Phosphatases (RPTPs) DLAR, PTP99A, PTP69D,PTP10D and PTP52F are involved in the axon guidance process of the fruit-fly Drosophila melanogaster. The receptors in these RPTPs comprise of Cell Adhesion Molecules (CAMs) whilethe cytosolic region contains the catalytic PTP domains. Extensive studies on the genetic interactions between these RPTPs reveal that these five RPTPs collaborate, compete or are partially redundant in some developmental contexts. While the genetic interactions between these RPTPs are well characterized, the role of domain-domain interactions and the mechanism(s) of substrate recognition are poorly understood. The aim of this study was to understand the molecular basis for these interactions using a combination of biophysical, biochemical and structural biology tools.
This thesis is organized as follows:
Chapter 1: The introductory chapter of this thesis highlights the mechanistic issues in signal transduction with an emphasis on the role of the RPTPs in the neuro-development of Drosophila melanogaster. The first part of this chapter describes the structural features and the catalytic mechanism of the PTP domain. This is followed by a description of the mechanisms that modulate the activity of a PTP domain. The latter part of the chapter summarizes the role ofthese RPTPs in axon guidance of Drosophila melanogaster. The interactions between the RPTPsbased on genetic data provide a mechanistic hypothesis that could be examined in vitro. The studies described in the subsequent chapters of this thesis were performed to evaluate this hypothesis.
Chapter 2: This chapter reports our observations on the so-called construct dependence on the expression of recombinant PTP domains in Escherichia coli. This chapter details the strategies used to obtain recombinant PTP domains in a soluble form suitable for biochemical and structural studies. This study involved substantial optimization in the size of the protein and overexpression strategies to avoid inclusion-body formation. Five strains of E. coli as well as three variations in purification tags viz., poly-histidine peptide attachments at the N-and C-termini and a construct with Glutathione-S-transferase at the N-terminus were examined. In this study, we observed that inclusion of a 45 residue stretch at the N-terminus was crucial for the over-expression of the PTP domains, influencing both the solubility and the stability of these recombinant proteins. While the addition of negatively charged residues in the N-terminal extension could partially rationalize the improvement in the solubility of these constructs, conventional parameters like the proportion of order-promoting residues or the aliphatic index did not correlate with the improved biochemical characteristics. The findings in this chapter suggest that the inclusion of additional parameters like secondary structure propensities apart from rigid domain predictions could play a crucial role in obtaining a soluble recombinant protein upon expression in E. coli.
Chapter 3: This chapter reports the crystal structure of the PTP domain of PTP10D and PTP10Dsubstrate/inhibitor complexes. These structural studies revealed aromatic ring stacking interactions that mediate substrate recruitment into the PTP active site. In particular, these studies revealed the role of conserved aromatic residue in Motif 1 (Phenylalaline 76 in case ofPTP10D). Mutation of Phenylalanine 76 residue to a Leucine (similar to the mutation found in the inactive distal PTP domains in other bi-domain PTPs) resulted in a sixty-fold decrease in the catalytic efficiency of the enzyme. Fluorescence kinetic measurements to monitor ligand binding showed a three fold increase in the half time of enzyme-ligand complex formation. These studies highlight the role of the KNRY loop in substrate recruitment at the active of the PTP domain and the role of this segment in modulating the kinetics of the enzyme-substrate complex formation.
Chapter 4: This chapter describes a strategy to utilize protein-protein interaction data to identify putative peptide substrates for a given protein. This study was performed in collaboration with Shameer Khader and Prof. R. Sowdhamini at the National Center for Biological Sciences (NCBS).This integrated search approach, called ‘PeptideMine’ was developed into a web-server for experimental and computational biologists. The Peptide Mine strategy combines sequence searches in the 'interacting sequence space' of a protein using sequence patterns or functional motifs. A compilation of indices that describe the chemical and solubility properties of potential peptide substrates to facilitate investigation by in vitro or in silico studies is also obtained from this server. The biological significance of such a design-strategy was examined in the context of protein-peptide interactions in the case of RPTPs of Drosophila melanogaster.
Chapter 5: In this chapter, we report an analysis of the influence of the membrane distal (D2) domain on the catalytic activity and substrate specificity of the membrane proximal (D1) domain using two bi-domain RPTPs as a model system. Biochemical studies reveal contrasting roles for the D2 domain of the Drosophila Leukocyte antigen Related (DLAR) and Protein Tyrosine Phosphatase on Drosophila chromosome band 99A (PTP99A). While D2 lowers the catalytic activity of the D1 domain in DLAR, the D2 domain of PTP99A leads to an increase in the catalytic activity of its D1 domain. Substrate specificity, on the other hand, is cumulative, whereby the individual specificities of the D1 and D2 domains contribute to the substrate specificity of these two-domain enzymes. Molecular dynamics simulations on structural models of DLAR and PTP99A revealed a conformational rationale for the experimental observations. These studies suggested that concerted structural changes mediate inter-domain communication resulting in either inhibitory or activating effects of the membrane distal PTP domain on the catalytic activity of the membrane proximal PTP domain.
Chapter 6: This chapter describes biochemical studies to understand the role of the D2 domain of PTP99A. While the catalytic activity of PTP99A is localized to its membrane proximal (D1)domain, the inactive membrane distal (D2) domain influences the catalytic activity of the D1domain. Phosphatase activity, monitored using small molecule as well as peptide substrates, suggested that the D2 domain activates D1. Thermodynamic measurements on the bi-domain(D1-D2 protein) as well as single domain PTP99A protein constructs suggest that the presence of the inactive D2 domain influences the stability of the bi-domain protein. The mechanism by which the D2 domain activates and stabilizes the bi-domain protein is governed by a few interactions at the inter-domain interface. In particular, we note that mutating Lys990 at the interface attenuates inter-domain communication. This residue is located at a structurally equivalent position to the so-called allosteric site of a canonical PTP, PTP1B. These observations suggest functional optimization in bi-domain RPTPs wherein the inactive PTP domain modulates the catalytic activity of the bi-domain enzyme.
Chapter 7: This chapter summarizes the experimental and computational studies on the Drosophila melanogaster PTP domains. The salient features of the experimental data that revealed hitherto uncharacterized sequence-structure relationships in the conserved PTP domain are highlighted. The latter part of this chapter briefly suggests the scope of future research in this area based on some of the findings reported in this thesis.
Appendix : This thesis has an appendix section with four parts. These comprise of technical details and auxiliary work that was not included in the main text of the thesis. Appendix I describes cloning strategies, purification protocols and a list of all recombinant proteins used in this study. Appendix II describes the standardization of the ‘Three Phase partitioning’ protocol for refolding and solubilization of protein from inclusion bodies. Appendix III includes theimmunochemical work performed to elucidate the localization of PTP10D in Drosophila embryos. Appendix IV describes the work on a Quercetin 2,3 Dioxygenase from Bacillus subtilis with an emphasis on the role of metal ions in modulating catalytic activity in this class of proteins.
|
43 |
Epidermal Growth Factor Stimulation of RPE Cell Survival: Contribution of Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase PathwaysDefoe, Dennis M., Grindstaff, Rachel D. 01 July 2004 (has links)
Epidermal growth factor (EGF) previously has been shown to stimulate short-term survival in vitro of cells derived from the native amphibian retinal pigment epithelium (RPE). In the present experiments, we have examined intracellular signaling pathways responsible for mediating these survival-specific growth factor effects, distinct from proliferative effects, using the human epithelial cell line RPE D407. When maintained as single cells in suspension culture in the absence of serum and exogenous survival factors, RPE D407 cell viability gradually declined over a 3-4 day period as a result of apoptotic cell death, a pattern similar to that seen for eye-derived RPE cells. Exposure to EGF (50 ng ml-1) enhanced cell survival by nearly 40% and caused a parallel increase in the tyrosine phosphate content of the EGF receptor (EGFR), as determined by immunoprecipitation and Western blotting. Both effects were completely blocked by 1μM AG1478, an EGFR-selective tyrosine kinase inhibitor. EGF also stimulated phosphorylation of the phosphatidylinositol 3′-kinase (PI3K)-dependent effector kinase Akt, as well as that of the MEK-dependent mitogen-activated kinase (MAPK), extracellular signal-regulated kinase (ERK). Furthermore, EGF-induced protection was substantially reduced by either the PI3K inhibitor LY294002 (25μM) or the MEK inhibitor U0126 (10μM), under conditions in which phosphorylation of Akt and ERK1/2, respectively, was blocked. Our results indicate that EGF-stimulated survival of RPE D407 cells takes place as a result of signaling through both PI3K and ERK/MAPK pathways. Further, residual anti-apoptotic activity stimulated by EGF in the presence of both blockers suggests that additional as yet unidentified growth factor-dependent survival pathways exist.
|
44 |
Regulation of papillomavirus E2 protein by posttranslational modificationCulleton, Sara Poirier 24 April 2015 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / Papillomaviruses (PVs) are small, double-stranded DNA viruses. Hundreds of species have evolved to replicate in mammals, birds, and reptiles. Approximately two hundred species are estimated to infect humans alone, and these human papillomaviruses (HPVs) cause diseases ranging from benign warts to anogenital and oropharyngeal cancers. While vaccination is effective at preventing the majority of these infections and their disease outcomes, there are no successful treatments for existing infections; thus, exploration of novel therapeutic targets is warranted.
PVs control expression and function of their gene products through alternative splicing, alternate start codons, and post-translational modification (PTM). The viral E2 protein regulates transcription, replication, and genome maintenance in infected cells, and PTMs have been demonstrated for E2 proteins from multiple papillomavirus types. Serine phosphorylation events were reported to influence E2 stability, and our laboratory was the first to describe in vitro acetylation events with implications for E2 transcription function. Here we report confirmation of these acetylation events in vivo and additional data elucidating the role of these PTMs in viral transcription. Moreover, we present a novel phosphorylation site for bovine papillomavirus type 1 (BPV-1) E2 at tyrosine 102 (Y102). Using phospho-deficient and phospho-mimetic point mutants, we found that this site influences E2-mediated transcription and replication, and we hypothesize that phosphorylation at Y102 regulates these activities by interrupting the association of E2 with its binding partners. We also report interaction of BPV-1 E2 and HPV-31 E2 with different receptor tyrosine kinases (TKs), most notably members of the fibroblast growth factor receptor family. We hypothesize that Y102 phosphorylation by these receptors occurs early in infection to limit viral replication and gene expression. Further studies will cement the role of RTKs in PV biology and could reveal novel therapeutic strategies.
|
45 |
Effect of nanoparticles on human cells from healthy individuals and patients with respiratory diseases.Osman, Ilham F. January 2010 (has links)
Ever increasing applications of nanomaterials (materials with one or more dimension
less than 100 nm) has raised awareness of their potential genotoxicity. They have
unique physico¿chemical properties and so could have unpredictable effects. Zinc oxide
(ZnO) and titanium dioxide (TiO2) are widely used in a number of commercial
products. There are published studies indicating that some forms of these compounds
may be photo-clastogenic in mammalian cells. What has not been investigated before is
the effect of nanoparticles from these compounds in human germ cells. Thus the
present study has examined their effects in the presence and absence of UV light in
human sperm and compared responses to those obtained with human lymphocytes using
the Comet assay to measure DNA damage. The effect of nanoparticles (40-70nm range)
was studied in human sperm and lymphocytes in the dark, after pre-irradiation with UV
and simultaneous irradiation with UV. The studies do provide some evidence that there
are photo-genotoxic events in sperm and lymphocytes in the absence of overt toxicity.
The cytotoxic and genotoxic potentials of ZnO and TiO2 as well as their effect on
phosphotyrosine expression, were examined in the human epithelial cervical carcinoma
cells (Hela cells). This was done to try and determine the underlying molecular events
resulting from their exposure to ZnO and TiO2 nanoparticles occurring at the same time
as DNA is damaged. Concentration- and time-dependent cytotoxicity, and an increase
in DNA and cytogenetic damage with increasing nanoparticle concentrations were
reported in this study. Mainly for zinc oxide, genotoxicity was clearly associated with
an increase in tyrosine phosphorylation.
Nanotechnology has raced ahead of nanotoxicology and little is known of the effects of
nanoparticles in human systems, let alone in diseased individuals. Therefore, the effects
of TiO2 nanoparticles in peripheral blood lymphocytes from patients with respiratory
diseases (lung cancer, chronic obstructive pulmonary disease (COPD) and asthma) were
compared with those in healthy individuals using genotoxic endpoints to determine
whether there are any differences in sensitivity to nano-chemical insult between the
patient and control groups. The results have shown concentration dependent genotoxic
effects of TiO2 in both respiratory patient and control groups in the Comet assay and an
increasing pattern of cytogenetic damage measured in the micronucleus assay without
being statistically significant except when compared with the untreated controls of
healthy individuals. Furthermore, modulation of ras p21 expression was investigated.
Regardless of TiO2 treatment, only lung cancer and COPD patients expressed
measurable ras p21 levels that showed modulation as the result of nanoparticle
treatment.
Results have suggested that both ZnO and TiO2 nanoparticles can be genotoxic over a
range of concentrations without either photoa-ctivation or being cytotoxic.
|
46 |
Binding Specificity of SH2 Domains Revealed by a Combinatorial Peptide LibraryKunys, Andrew Richard 27 September 2013 (has links)
No description available.
|
47 |
Synthèse et évaluation biologique de nouveaux inhibiteurs de kinases : identification d‘inhibiteurs de kinases parasitaires / Synthesis and biological evaluation of new kinase inhibitors : identification of inhibitors of several parasite protein kinasesBendjeddou, Lyamin 14 October 2014 (has links)
La phosphorylation des protéines par les kinases est l’une plus importantes modification post-traductionnelle dans les processus cellulaires tels que la division, la différenciation, la prolifération et l’apoptose. Due à leur rôle clef, un dérèglement des protéines kinases peut entrainer de nombreuses pathologies proliférative telles que le cancer et non prolifératives telles que les maladies neurodégénératives. Le travail de thèse s’est construit autour de 2 séries d’inhibiteurs de protéine kinases comportant les noyaux imidazo[1,2-b]pyridazine et imidazo[4,5-b]pyridine. L’objectif est d’inhiber sélectivement les protéines kinases choisies, pour leurs implications dans les pathologies visées au laboratoire. Les imidazo[1,2-b]pyridazines ont été préparées pour identifier des inhibiteurs de CLK1 et DYRK1A, cibles potentielles dans la maladie d’Alzheimer. Parmi les imidazo[1,2-b]pyridazines synthétisées, plusieurs molécules se sont révélées particulièrement sélectives de DYRKs et CLKs, avec des IC50 < 100 nM. Une relation structure-activité basée sur la synthèse de 70 molécules, a permis de dégager des éléments structuraux de la sélectivité des molécules. L’évaluation des produits a également été portée sur les kinases de parasites. Il a ainsi été possible d’identifier quelques inhibiteurs actifs sur PfCLK1. La seconde partie de cette thèse avait pour objectif l’optimisation du protocole de synthèse imidazo[4,5-b]pyridines, analogue de la roscovitine. Des dérivés s’étaient révélés capables d’inhiber la formation de kystes, dans un modèle cellulaire de polykystose rénale. Une synthèse en sept étapes a conduit à plusieurs grammes d’imidazo[4,5-b]pyridine 3,5,7 trisubstitués, qui sont ainsi disponibles pour l’évaluation in vivo. / Phosphorylation by protein kinases is one of the most important post-translational modification in cellular processes such as division, differentiation, proliferation and apoptosis. Kinase deregulation is associated with numerous diseases such as cancer or neurodegenerative diseases. Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine were prepared to inhibit protein kinases involved in diseases targeted in the laboratory. The imidazo[1,2-b]pyridazines were synthesized to identify inhibitors of CLK1 and DYRK1A, potential targets in Alzheimer's disease. Among the imidazo[1,2-b]pyridazines synthesized, several molecules were found selective of DYRKs and CLKs, with IC50 < 100 nM. A structure-activity relationship based on the synthesis of 70 molecules, led to the identification of the structural bases of the selectivity. Products were also evaluated against parasite kinases. It was possible to identify some highly potent inhibitors on PfCLK1. The aim of second part of this thesis was to optimize the synthetic process to obtain imidazo[4,5-b]pyridines, which are close analogues of roscovitine. Derivatives had proved capable of inhibiting the formation of cysts in a cellular model of polycystic kidney disease. A seven-step synthesis has led to several grams of 3,5,7-trisubstituted imidazo[4,5-b]pyridine which is now available for evaluation in vivo.
|
48 |
Assembly and analysis of a comprehensive phosphotyrosine-dependent protein-protein interaction networkGroßmann, Arndt 29 March 2016 (has links)
Protein-Protein-Wechselwirkungen steuern zelluläre Funktionen auf molekularer Ebene. Posttranslationale Proteinmodifikationen beeinflussen diese Wechselwirkungen und erlauben dynamische Regulierung. Tyrosinphosphorylierung ist eine besonders relevante Modifikation, weil sie eng mit interzellulärer Regulation von Wachstum und Enticklung in Vielzellern verbunden ist. Da falsche Regulierung dieser Prozesse zu Krebs oder Autoimmunerkrankungen führen kann, ist sie auch von großem medizinischen Interesse. In Hefe-Zwei-Hybrid- Untersuchungen mit Volllängen-Proteinen im Genommaßstab wurde ein umfassender Satz von 292 größtenteils neuen phosphotyrosinabhängigen Proteinwechselwirkungen erster Güte ermittelt. Damit wurde eine Wissenslücke im Bereich der phosphotyrosinabhängigen Signalübertragung, der bisher hauptsächlich auf Peptidbindungs- und Affinitätsaufreinigungs-gekoppelten Massenspektronomieexperimenten fußte. Die Güte der Interaktionen wurde experimentell und informatisch, in Coimmunpräzipitations- und Proteinkomplementierungs-, sowie in Überrepräsentationsanalysen und Literaturvergleichen, gezeigt. Bekannte lineare Bindesequenzmotive kommen zwar gehäuft vor, können die Mehrzahl der Interaktionen aber offensichtlich nicht erklären. Die Wechselwirkungen bilden ein dichtes, einheitliches Netzwerk und widerspiegeln phosphotyrosinabhängige KEGG-Signalwege. Es hat ein Herzstück aus acht Genen, von denen sieben fest etablierte Signalverarbeitungshauptknotenpunkte darstellen. Dem achten, SH2D2A, scheint eine deutlich wichtigere Rolle zuzukommen als bisher wahrgenommen. Schliesslich wurde für eine Auswahl von GRB2-Interaktionen unterschiedliche subzelluläre Verortung vorgenommen. Zusammengenommen legen diese Ergebnisse nah, dass die hier veröffentlichten Wechselwirkungen einen wesentlichen Schritt für das Verstehen von Wachstum und Entwicklung markieren und zur Verbesserung der Behandlungsmöglichkeiten in wichtigen Medizinbereichen beitragen werden. / Protein-protein interactions govern cellular functions on the molecular level. Post-translational modifications alter these interactions allowing highly dynamic regulation. Protein tyrosine phosphorylation is an especially relevant post-translational modification, because it is tightly linked to intercellular regulation of growth and development in metazoans. Diseases like cancer or autoimmune disorders arise from misregulation of these processes generating great medical interest in protein tyrosine phosphorylation and processes relating to it. This study provides a comprehensive set of 292 mostly novel, high-quality phosphotyrosine- dependent protein-protein interactions detected in genome-scale yeast two-hybrid screens using full-length proteins filling a gap in phosphotyrosine signaling knowledge, which has so far been based largely on peptide binding and affinity purification-coupled mass spectrometry experiments. The high quality was demonstrated experimentally and computationally, in co-immunoprecipitation and protein complementation assays, as well as over-representation analyses and comparison to prior knowledge. Previously reported linear peptide motifs are reflected in the binding partners, but clearly do not account for most of the interactions, emphasizing the relevance of full-length protein context. The interactions were further shown to form an unusually dense, monolithic network with a central core and reflect and expand phosphotyrosine-related KEGG pathways. Seven of the eight core proteins are well-established signaling hubs. The eighth core gene, SH2D2A, seems to play a more central role than currently appreciated. Finally, selected interactions involving GRB2 were shown to occur in different specific subcellular localizations. Together, these results strongly suggest that the interactions presented here represent an important step toward understanding growth and development and will benefit treatment of pressing medical issues substantially.
|
49 |
INHIBITION OF ERYTHROCYTE BAND 3 TYROSINE PHOSPHORYLATION: CHARACTERIZATION OF A NOVEL THERAPY FOR SICKLE CELL DISEASE AND MALARIAPanae Noomuna (10716546) 29 April 2021 (has links)
While the molecular
defect that cause sickle cell disease has well been established, the cause of
vaso-occlusive crisis remains elusive and largely debated upon. Majority of
studies have linked the painful episodes to polymerization of sickle hemoglobin
following its deoxygenation. The variability of the disease symptoms among
patients, compounds efforts for a holistic therapy. Hydroxyurea, a stimulator
of Hb F induction and a widely used treatment, has ameliorated the complication
of SCD but it is only effective in 50% of the patients. Expression of Hb F
lowers the content of Hb S in blood and hence reduces oxidative stress caused
by Hb S denaturation. Sickle cell disease severity depends on several factors.
Most importantly, the ability of red cell to sickle dominates all other
determinants. While deoxygenation of sickle hemoglobin may be inevitable, the
duration with which the red cell remains in the deoxygenated state can be
manipulated. Deoxygenation is a transient process that when compared to the
time taken to develop the long filaments of deoxyhemoglobin to causes severe
sickling, the red cell would have been cycled back to the lungs and
re-oxygenated to restore the healthy conditions of the cell. In fact, if sickle
cells would flow as fast as healthy erythrocytes, the detrimental impacts of
sickling such as vaso-occlusive crisis, would not be a concern for this
disease. Unfortunately, the unstable sickle hemoglobin undergoes denaturation
through auto-oxidation, which imposes oxidative stress to the cells. The
oxidative stress inhibits erythrocytes tyrosine phosphatases, a course which
subsequently impair their constitutive action against the tyrosine kinases. In
the end, a net tyrosine phosphorylation state in the red cell membrane
proteins, most notably the transmembrane protein band 3, succeeds. Band 3
tyrosine phosphorylation abrogates the protein’s interaction with ankyrin and
spectrin-actin cytoskeleton, hence the cytoskeleton loses its major anchorage
to the membrane thus engendering membrane destabilization. A destabilized
erythrocyte sheds membrane fragments in form of microvesicles/microparticles
and discharges free hemoglobin into the extra cellular matrix. In consequence,
the microparticles power initiation of coagulation cascade through activation of
thrombin, while free Hb inflicts inflammation, scavenges nitric oxide which is
necessary for vasodilation and induces further oxidative stress within the
microvasculature, and activates expression of adhesion receptors on the
endothelium. Taken together, these events culminate in entrapment of red cells
(not naming leucocytes and platelets) in the microvasculature, blockade of
blood vessels and further damage of erythrocytes through prolonged deoxygenated
state thus terminating in tissue injury, strokes, and organ damage, amid
vaso-occlusive episodes which always require hospitalization and extensive
medical care for survival. Band 3 tyrosine phosphorylation and membrane
weakening is not unique just to SCD, but also a druggable target for malaria.
Malaria, a disease that is touted as the evolutionary cause of sickle cell
disease, surprisingly thrives through the same mechanism. Briefly, malaria
parasite consumes hemoglobin for its DNA synthesis, and in the process generate
reactive oxygen species from denatured hemoglobin that feeds into the oxidative
stress which triggers band 3 tyrosine phosphorylation. In this case however, a
destabilized membrane offers perfect conditions for merozoites’ (malaria
daughter parasites) egress/exit out of the cell to begin infecting other red
cells. Ultimately, the ensuing anemia and organ dysfunction leads to patient’s
death. Treatment of diseased cells with imatinib and other Syk inhibitors
effectively reversed membrane weakening. A stabilized membrane not only
survives longer in circulation to alleviate SCD symptoms but also traps and
starves malaria parasite leading to termination of the parasitic infection.
With band 3 tyrosine phosphorylation at center stage, this dissertation
explores the above events in an effort to unveil a novel therapy for sickle
cell and malaria diseases. First, the therapeutic strategy regarding SCD is
discussed in detail beginning with non-transfused patients and ending in
additional mechanistic study on inactivation of the principal erythrocyte’s protein
tyrosine phosphatase 1 B, PTP1B. The dissertation then provides an initial
proof of concept on efficacy of imatinib in treatment of malaria as a
monotherapy and its efficacy when used in a triple combination therapy with the
standard of care treatment. Finally, I outline an alternative possible
mechanism of action of quinine against malaria.
|
50 |
Structural and functional investigation of the C-terminal intrinsically disordered fragment of ErbB2 / Exploration structurale et fonctionnelle de la partie C-terminale intrinsèquement désordonnée de ErbB2Pinet, Louise 17 October 2019 (has links)
ErbB2/HER2 est un récepteur tyrosine kinase de la famille d'EGFR (ErbB1) surexprimé dans plus de 20% des cancers du sein et associé à une forme particulièrement agressive de la maladie. Les récepteurs ErbBs sont actifs seulement sous forme de dimères, permettant la phosphorylation de leur queue C-terminale par leur domaine tyrosine kinase. La phosphorylation entraine l'interaction avec des protéines adaptatrices et l'activation de voies de signalisation, Ras/MAPK et PI3K/Akt principalement. Ces voies contrôlent la prolifération, la motilité cellulaire et la résistance à l'apoptose. Contrairement à ErbB1/3/4, ErbB2 dimérise en l'absence de ligand. Comprendre les autres mécanismes de régulation de la phosphorylation de ses tyrosines et de ses interactions est donc particulièrement intéressant.ErbB2 a fait l'objet de nombreuses études structurales et fonctionnelles. Elles ont permis la mise au point de traitements ciblés efficaces mais sujets à l'apparition de résistance, dont l'anticorps Trastuzumab, ciblant sa partie extracellulaire. La queue C-terminale d'ErbB2 (CtErbB2) a été très souvent ignorée dans ces études. Cette partie étant intrinsèquement désordonnée, il a fallu attendre ces dernières années pour que les concepts et les outils permettant de l'étudier émergent.Dans cette thèse, j'ai d'abord effectué la caractérisation structurale et dynamique de CtErbB2. J'ai montré que bien qu'étant dépourvue de toute structure stable, cette région riche en prolines possède plusieurs structures secondaires transitoires et un contact longue-distance participant très probablement à la régulation de ses interactions intra- et inter-moléculaires. Dans une deuxième partie je me suis intéressée à la caractérisation de la protéine adaptatrice Grb2, partenaire essentiel de ErbB2 pour l'activation de la voie des MAP kinases. L'organisation en solution des domaines de cette protéine modulaire dans sa forme libre était jusque là inconnue. J'ai ensuite étudié l'interaction entre Grb2 et CtErbB2, et montré que CtErbB2 interagit non seulement avec le domaine SH2 de Grb2 (par l'intermédiaire d'une phosphotyrosine), mais aussi avec son domaine SH3 N-terminal (grâce à un motif polyproline). Enfin, j'ai mis en place plusieurs stratégies de phosphorylation des tyrosines de CtErbB2, dans le but d'étudier plus largement l'effet des phosphorylations sur l'ensemble de cette région. / ErbB2/HER2 is a receptor tyrosine kinase of the EGFR (ErbB1) family overexpressed in 20% of breast cancers and associated to a particularly aggressive form of the disease. ErbB receptors are only active upon dimerization that enables phosphorylation of their C-terminal tail by their tyrosine kinase domain. Phosphorylation then triggers interaction with adaptor proteins and activation of signaling pathways, mainly Ras/MAPK and Akt/PI3K. Those pathways control cell proliferation, motility and resistance to apoptosis. Contrary to ErbB1/3/4, ErbB2 can dimerize without any ligand. Understanding other mechanisms of regulation of its tyrosine phosphorylation and of its interactions is thus particularly interesting.ErbB2 structure and function have been extensively studied. This has led to the development of several FDA-approved targeted drugs, that are effective but to which resistance occurs, amongst which the Trastuzumab antibody that targets ErbB2 extracellular domain. The C-terminal tail of ErbB2 (CtErbB2) has been widely ignored in these studies. Since it is intrinsically disordered, the concepts and tools to study it have only emerged in the last few years.In the present work, I have performed the structural and dynamic study of CtErbB2. I showed that despite its lack of any stable structure, this proline-rich region exhibits several transient secondary structures and a long-range contact that might participate in the regulation of its intra- and inter-molecular interactions. Then, I characterized the adaptor protein Grb2, which is a partner of ErbB2 that is essential for the activation of the MAPK pathway. The solution organization of the domains of this modular protein in its apo-form was unknown so far. I also studied the interaction between Grb2 and CtErbB2, showing that in addition to the known SH2-phosphotyrosine interaction, a polyproline motif of CtErbB2 binds to the N-terminal SH3 domain of Grb2. Finally, I implemented several strategies to phosphorylate CtErbB2 tyrosines, to study more extensively the effect of phosphorylation on the whole tail.
|
Page generated in 0.1876 seconds